- Home
- SKK vs CSCI Comparison
SKK vs CSCI Comparison
Compare SKK & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKK
- CSCI
- Stock Information
- Founded
- SKK 2013
- CSCI 1990
- Country
- SKK Singapore
- CSCI Canada
- Employees
- SKK N/A
- CSCI N/A
- Industry
- SKK
- CSCI
- Sector
- SKK
- CSCI
- Exchange
- SKK NYSE
- CSCI NYSE
- Market Cap
- SKK 12.0M
- CSCI 10.6M
- IPO Year
- SKK 2024
- CSCI 1996
- Fundamental
- Price
- SKK $0.58
- CSCI $3.80
- Analyst Decision
- SKK
- CSCI
- Analyst Count
- SKK 0
- CSCI 0
- Target Price
- SKK N/A
- CSCI N/A
- AVG Volume (30 Days)
- SKK 51.4K
- CSCI 5.1K
- Earning Date
- SKK 02-14-2025
- CSCI 08-12-2025
- Dividend Yield
- SKK N/A
- CSCI N/A
- EPS Growth
- SKK 99.13
- CSCI N/A
- EPS
- SKK 0.03
- CSCI N/A
- Revenue
- SKK $11,301,000.00
- CSCI $9,030,000.00
- Revenue This Year
- SKK N/A
- CSCI N/A
- Revenue Next Year
- SKK N/A
- CSCI N/A
- P/E Ratio
- SKK $20.75
- CSCI N/A
- Revenue Growth
- SKK 15.80
- CSCI 36.51
- 52 Week Low
- SKK $0.53
- CSCI $1.96
- 52 Week High
- SKK $11.45
- CSCI $6.77
- Technical
- Relative Strength Index (RSI)
- SKK N/A
- CSCI N/A
- Support Level
- SKK N/A
- CSCI N/A
- Resistance Level
- SKK N/A
- CSCI N/A
- Average True Range (ATR)
- SKK 0.00
- CSCI 0.00
- MACD
- SKK 0.00
- CSCI 0.00
- Stochastic Oscillator
- SKK 0.00
- CSCI 0.00
About SKK SKK HOLDINGS LIMITED
SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.